BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28509990)

  • 21. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
    Senís E; Mosteiro L; Grimm D; Abad M
    Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.
    Li R; Liang J; Ni S; Zhou T; Qing X; Li H; He W; Chen J; Li F; Zhuang Q; Qin B; Xu J; Li W; Yang J; Gan Y; Qin D; Feng S; Song H; Yang D; Zhang B; Zeng L; Lai L; Esteban MA; Pei D
    Cell Stem Cell; 2010 Jul; 7(1):51-63. PubMed ID: 20621050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells.
    Di Stefano B; Sardina JL; van Oevelen C; Collombet S; Kallin EM; Vicent GP; Lu J; Thieffry D; Beato M; Graf T
    Nature; 2014 Feb; 506(7487):235-9. PubMed ID: 24336202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
    Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
    Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
    Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
    Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deciphering the roadmap of in vivo reprogramming toward pluripotency.
    Chondronasiou D; Martínez de Villarreal J; Melendez E; Lynch CJ; Pozo ND; Kovatcheva M; Aguilera M; Prats N; Real FX; Serrano M
    Stem Cell Reports; 2022 Nov; 17(11):2501-2517. PubMed ID: 36270281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming human fibroblasts using HIV-1 TAT recombinant proteins OCT4, SOX2, KLF4 and c-MYC.
    Pan C; Lu B; Chen H; Bishop CE
    Mol Biol Rep; 2010 Apr; 37(4):2117-24. PubMed ID: 19669668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human fibroblast reprogramming to pluripotent stem cells regulated by the miR19a/b-PTEN axis.
    He X; Cao Y; Wang L; Han Y; Zhong X; Zhou G; Cai Y; Zhang H; Gao P
    PLoS One; 2014; 9(4):e95213. PubMed ID: 24740298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
    Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
    Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog.
    Wang X; Hodgkinson CP; Lu K; Payne AJ; Pratt RE; Dzau VJ
    Sci Rep; 2016 Mar; 6():23017. PubMed ID: 26975336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reprogramming bladder cancer cells for studying cancer initiation and progression.
    Iskender B; Izgi K; Canatan H
    Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of human and mouse fibroblasts into lung-like epithelial cells.
    Wong AP; Shojaie S; Liang Q; Xia S; Di Paola M; Ahmadi S; Bilodeau C; Garner J; Post M; Duchesneau P; Waddell TK; Bear CE; Nagy A; Rossant J
    Sci Rep; 2019 Jun; 9(1):9027. PubMed ID: 31227724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Directing reprogramming to pluripotency by transcription factors.
    Adachi K; Schöler HR
    Curr Opin Genet Dev; 2012 Oct; 22(5):416-22. PubMed ID: 22868173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.
    Vazquez-Martin A; Vellon L; Quirós PM; Cufí S; Ruiz de Galarreta E; Oliveras-Ferraros C; Martin AG; Martin-Castillo B; López-Otín C; Menendez JA
    Cell Cycle; 2012 Mar; 11(5):974-89. PubMed ID: 22333578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of Induced Cardiospheres via Reprogramming of Skin Fibroblasts for Myocardial Regeneration.
    Xu JY; Lee YK; Ran X; Liao SY; Yang J; Au KW; Lai WH; Esteban MA; Tse HF
    Stem Cells; 2016 Nov; 34(11):2693-2706. PubMed ID: 27333945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
    Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
    Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial acceleration of mammalian cell reprogramming by bacterial proteins.
    Ikeda T; Uchiyama I; Iwasaki M; Sasaki T; Nakagawa M; Okita K; Masui S
    Genes Cells; 2017 Oct; 22(10):918-928. PubMed ID: 28776863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological importance of OCT transcription factors in reprogramming and development.
    Kim KP; Han DW; Kim J; Schöler HR
    Exp Mol Med; 2021 Jun; 53(6):1018-1028. PubMed ID: 34117345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of induced pluripotent stem cells by using a mammalian artificial chromosome expression system.
    Tóth A; Fodor K; Blazsó P; Cserpán I; Praznovszky T; Tubak V; Udvardy A; Hadlaczky G; Katona RL
    Acta Biol Hung; 2014 Sep; 65(3):331-45. PubMed ID: 25194736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.